Table 2

Change in the RDQ scales from baseline to 2 weeks, by patient rating of the Overall Treatment Evaluation (OTE)

OTE
N
Heartburn
Regurgitation
Dyspepsia
GERDa





Mean
SD
Mean
SD
Mean
SD
Mean
SD

Esomeprazole
Worse
6
0.04
2.00
-0.42
0.41
-0.08
1.47
-0.19
1.20
The same
36
0.76
1.48
0.68
1.11
0.31
1.24
0.71
0.99
A little better
43
1.60
1.46
1.52
1.08
1.27
1.64
1.56
0.97
Much better
231
2.74
1.26
2.25
1.42
1.94
1.59
2.51
1.08
All
316
2.31
1.52
1.92
1.47
1.64
1.66
2.12
1.26
Placebo
Worse
3
0.42
1.18
-0.25
0.25
0.50
0.43
0.08
0.63
The same
26
0.42
1.54
0.37
1.30
0.27
1.41
0.37
1.08
A little better
28
0.88
1.0
1.05
1.10
0.78
1.20
0.90
0.72
Much better
22
2.10
1.26
1.38
1.82
1.65
1.68
1.74
1.33
All
79
1.05
1.43
0.86
1.43
0.86
1.50
0.93
1.17

aHeartburn and regurgitation subscales combined. SD, standard deviation.

Shaw et al. Health and Quality of Life Outcomes 2008 6:31   doi:10.1186/1477-7525-6-31